• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Lipid Therapeutics - Articles and news items

Lipid-based formulations: Their advantages in early development

Blog, Z Homepage promo / 21 March 2017 / Kaspar van den Dries PhD, Senior Director and Principal Scientist, Solid Dose Development, Patheon

Patheon’s Kaspar van den Dries shows the advantages of considering lipid formulation in early development to optimise a molecule’s developability…

Positive results for Infirst’s Phase III lipid formulated ibuprofen trial

Industry news / 4 October 2016 / Niamh Louise Marriott, Digital Content Producer

The study met its primary objective which was to determine if 1200mg/day of BC1054 lipid formulated ibuprofen was non-inferior to standard soft gel ibuprofen capsules…

ABITEC announces extension of product portfolio and enters new market

ABITEC announces extension of product portfolio and enters new market

Supplier news / 19 September 2016 / ABITEC Corporation

ABITEC Corporation continues to add new innovations and dosage form applications to their already expansive product portfolio…

Lipid Therapeutics licenses rights to LT-02 to Nestlé Health Science

Industry news / 17 September 2015 / Victoria White

LT-02 is a novel barrier function therapy for patients with mild-to-moderate ulcerative colitis…